Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CIPROFLOXACIN INJECTION DIN 02377535

Status: Cancelled Post Market
Holder: OMEGA LABORATORIES LIMITED
Molecule: CIPROFLOXACIN (CIPROFLOXACIN LACTATE)

Health Canada record

Active ingredient(s)CIPROFLOXACIN (CIPROFLOXACIN LACTATE) 2 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01MA02 CIPROFLOXACIN
Original market date17-Apr-2012
Current status date13-Mar-2019
SourceHealth Canada DPD

Establishment licence of the holder

Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — licence 100277, not currently licensed, last inspection rating C (2025-05-20).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CIPROFLOXACIN (CIPROFLOXACIN LACTATE)

DINProductCompanyFormStrengthStatus
02155982CIPRO I.V. - LIQ 10MG/MLBAYER INCLiquidCIPROFLOXACIN (CIPROFLOXACIN LACTATE) 10 MGCancelled Post Market
01947710CIPRO IV 10MG/MLMILES CANADA INC. - PHARMACEUTICAL DIVISIONLiquidCIPROFLOXACIN (CIPROFLOXACIN LACTATE) 10 MGCancelled Post Market
02274140CIPROFLOXACIN INJECTIONFRESENIUS KABI CANADA LTDSolutionCIPROFLOXACIN (CIPROFLOXACIN LACTATE) 10 MGCancelled Pre Market
02301296CIPROFLOXACIN INJECTIONBAXTER CORPORATIONSolutionCIPROFLOXACIN (CIPROFLOXACIN LACTATE) 2 MGCancelled Post Market
02464942CIPROFLOXACIN INJECTIONSTERIMAX INCSolutionCIPROFLOXACIN (CIPROFLOXACIN LACTATE) 0.2 %Cancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
129402012-01-19Abbreviated New Drug Submission (ANDS)New manufacturer and oriduct name
Request a quote for CIPROFLOXACIN INJECTION

How to read a Canadian DIN record